Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

972
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
972
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

4.4K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

741
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741
Cross-bridge Cycle01:26

Cross-bridge Cycle

124.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
124.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of baclofen and lorazepam on interhemispheric inhibition in humans.

Experimental physiologyยท2026
Same author

Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy.

Journal of cachexia, sarcopenia and muscleยท2026
Same author

Muscle mitochondrial changes in antisynthetase syndrome and other idiopathic inflammatory myopathies.

Journal of neuropathology and experimental neurologyยท2025
Same author

Impact of high-intensity interval training on cardiometabolic health in patients with diabesity: a systematic review and meta-analysis of randomized controlled trials.

Diabetology & metabolic syndromeยท2025
Same author

A Multi-Ingredient Supplement Improves Body Re-Composition, Ovarian Aging Markers, and Reproductive Success in Young and Middle-Aged Female Mice.

Biomoleculesยท2025
Same author

Multi-ingredient supplementation for combating sarcopenia and polymorbidity.

Current opinion in clinical nutrition and metabolic careยท2025

Related Experiment Video

Updated: Mar 10, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

16.1K

Metabolic Myopathies.

Mark A Tarnopolsky

    Continuum (Minneapolis, Minn.)
    |December 7, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Metabolic myopathies are genetic muscle disorders affecting energy production. Early diagnosis through clinical and genetic testing enables lifestyle and nutritional interventions for better outcomes.

    More Related Videos

    Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
    09:40

    Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

    Published on: January 19, 2017

    12.3K
    Tissue Triage and Freezing for Models of Skeletal Muscle Disease
    05:58

    Tissue Triage and Freezing for Models of Skeletal Muscle Disease

    Published on: July 15, 2014

    41.7K

    Related Experiment Videos

    Last Updated: Mar 10, 2026

    Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
    09:39

    Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

    Published on: July 29, 2016

    16.1K
    Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
    09:40

    Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

    Published on: January 19, 2017

    12.3K
    Tissue Triage and Freezing for Models of Skeletal Muscle Disease
    05:58

    Tissue Triage and Freezing for Models of Skeletal Muscle Disease

    Published on: July 15, 2014

    41.7K

    Area of Science:

    • Neurology
    • Genetics
    • Metabolic Disorders

    Background:

    • Metabolic myopathies are genetic disorders impacting skeletal muscle intermediary metabolism.
    • Key defects involve glycolysis/glycogenolysis, fatty acid oxidation, and mitochondrial respiratory chain function.

    Observation:

    • Presentation varies from neonatal systemic involvement (hypotonia, hypoglycemia) to childhood/adult exercise intolerance and weakness.
    • Specific myopathies correlate with exercise type (high-intensity vs. endurance) or metabolic stress.
    • Diagnostic evaluation includes exercise testing, blood/urine analysis, muscle biopsy, MRI, and genetic testing.

    Findings:

    • Clinical examination may be normal between acute episodes.
    • A comprehensive diagnostic algorithm is crucial for identifying these rare genetic disorders.
    • Early and accurate diagnosis facilitates timely therapeutic interventions.

    Implications:

    • Therapeutic strategies include lifestyle and nutritional modifications, cofactor treatment, and prompt management of rhabdomyolysis.
    • Developing a diagnostic and treatment algorithm aids clinicians in managing metabolic myopathies.
    • Improved diagnostic approaches can lead to better patient outcomes and quality of life.